Health Policy, Life Science and Pharmaceuticals

What Person-Centered Interoperability Looks Like: Seqster

Health Populi

APRIL 6, 2022

This capability is attracting pharmaceutical and life science companies, health care providers and research organizations to take a closer look at Seqster’s offering. In summing up the patient-centered interoperability goal, Ardy summarized: “We’ve created the Mint.com of health data.”

Interoperability

Interoperability Life Science EHR Health Data

Health Care Nation – How to Inspire a Rosa Parks Moment for Healthcare in America?

Health Populi

MARCH 26, 2025

Tom Lawry may be best-known as a leading voice on AI in health care; after all, hes written two very well-selling books on the topic, speaks all over the world on the subject, and in his most recent company-based gig helped lead Microsofts efforts in AI in health care and life sciences.

Health Policy

Health Policy Leadership Life Science Nursing

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

MARCH 11, 2021

The coolest thing in health policy in the 21st century!! ” Amitabh Chandra gave the opening context-setting talk about the effects of health care cost-sharing on patients-as-consumers. Kavita Patel to assert in the first panel of the day that, “2713 is my favorite number.”

Health Policy

Health Policy Medicare Pharmaceuticals Life Science

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

What Your Financial Statements Are Telling You—And How to Listen!

MORE WEBINARS

McKinsey’s Six Shifts To Add Life to Years — and One More to Consider

Health Populi

APRIL 1, 2022

To innovate more, and more quickly, across the entire ecosystem of health — in government policies, pharmaceutical innovations, and technology developments. ” This is akin to our pointing out over the past years that every company is a health company.

Life Science

Life Science Mental health Pharmaceuticals Medical Technology

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

JUNE 24, 2021

The economic and healthcare system impacts of this were explored in the Post-Covid Healthcare Landscape , delivered by Fitch Solutions’ Jamie Davies and Beau Noafshar, leaders in the Pharmaceuticals, Healthcare, and Medical Devices groups.

BioTech

BioTech Pharmaceuticals Public Health Telehealth

Well-Being Burnout – Lululemon’s 4th Annual Study Into Our Pressured Lives

Health Populi

SEPTEMBER 25, 2024

We can’t expect the health care system — hospitals, physicians and nurses, pharmacists and life science companies — to solve this problem for patients and caregivers. The bottom line: those who are more connected to their community report 16% greater well-being and are more likely to feel a sense of purpose.

Life Science

Life Science Nursing Pharmaceuticals Patient Experience

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

OCTOBER 28, 2019

patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. Over one-half of Americans blame pharmaceutical companies as most responsible for the opioid crisis, followed by physicians, whom 39% of health consumers blame, and patients, whom 38% of people blame. Exacerbating U.S.

Pharmaceuticals

Pharmaceuticals Medical Billing Medicare Mental health

Social Determinants of Health – My Early Childhood Education and Recent Learnings, Shared at the HealthXL Global Gathering

Health Populi

NOVEMBER 19, 2019

In the past decade, I’ve been spending a lot of time considering SDoH through a variety of lenses across the health/care ecosystem, including care providers like hospitals, health insurance companies, pharma and life science, retail health care front doors, and non-profits and foundations.

Medicare

Medicare Life Science Leadership Pharmaceuticals

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Health Populi

MAY 4, 2023

Reviewing the annual 2023 report from the IQVIA Institute for Human Data Science discussing The Use of Medicines in the U.S. It’s a volume speaking volumes on the current picture of prescribed meds, spending and revenues, health care utilization trends, and a forecast looking out to 2027.

Public Health

Public Health Mental health Life Science Telehealth

Medical costs projected to increase 6% by 2020, says PwC

Henry Kotula

JULY 1, 2019

The trend has implications for employers, payers, providers and even pharmaceutical and life science companies. Payers and employers are aiming to grow the role of telemedicine as employees grow more comfortable with it, especially if out-of-pocket costs are lower and the quality doesn’t suffer.

Life Science

Life Science Pharmaceuticals Mental health Telemedicine

Wasted: $1 of Every $4 Spent on Health Care In America

Health Populi

OCTOBER 8, 2019

More savings would accrue through the quicker adoption of value-based payment models, the authors assert, where clinicians take on financial risk for managing population health. Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research.

Pharmaceuticals

Pharmaceuticals Medicare Life Science Health Policy

Can a Food-As-Medicine App Extend Chronic Health Management at the Grocery Store?

Health Populi

MARCH 28, 2022

For many years, I’ve advocated for siloes to break down so that these organizations, all of which have mission statements that speak to benefit patient care and health outcomes, to more effective reach those Holy Grails.

Life Science

Life Science mHealth Primary Care Pharmaceuticals

Healthcare AI investment will shift to these 5 areas in the next 2 years: survey

Henry Kotula

MARCH 10, 2021

The majority of healthcare and life sciences executives (82%) want to see their organizations more aggressively adopt AI technology, according to a new survey from KPMG, an audit, tax and advisory services firm. However, life sciences companies seem to be struggling to select the best AI technologies, according to 73% of executives.

Life Science

Life Science Pharmaceuticals Drug Development EHR

In 2020, PwC Expects Consumers to Grow DIY Healthcare Muscles As Medical Prices Increase

Health Populi

DECEMBER 11, 2019

In this 14th year of the publication, PwC polled executives from payers, providers, and pharma/life science organizations. Internally, health industry business leaders are prioritizing several workforce strategies in the new year, first and foremost to confront digital transformation.

Life Science

Life Science Medical Billing Health Data Primary Care

The 2021 Shkreli Awards: Lown Institute Counts Down the Top 10 Healthcare Industry Abuses in the Coronavirus Pandemic

Health Populi

JANUARY 5, 2021

When he led Turing Pharmaceuticals in 2015, he acquired a license for the drug Daraprim (an anti-malarial therapy also used for HIV/AIDS), raising the drug price from $13.50 A quick sidebar for context: The Awards are named for Martin Shkreli, the so-called “Pharma Bro” who managed hedge funds and pharma companies.

Public Health

Public Health Pharmaceuticals Leadership Life Science

Measuring Progress for Life Sciences: Trust, Patient Access, and Prevention at a Fork in the Road of Public Health

Health Populi

JANUARY 31, 2025

How will we know if the life sciences sector is advancing in 2025? This is the question asked at the start of the report, a Research Brief: 2025 Indicators of Progress for the Life Sciences Sector, from the IQVIA Institute for Human Data Science (IQVIA). We start with the state of trust held by U.S.

Life Science

Life Science Public Health Primary Care Pharmaceuticals

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Health Populi

MARCH 6, 2019

That would be profits made by pharmaceutical companies, cited by 80% of respondents. Ironic that in this Congressional session, pharmaceutical manufacturers are testifying about the life-saving benefits of their products, but priced to drive about one-third of Americans not to adopt them. consumers were asked.

Pharmaceuticals

Pharmaceuticals Medicare Life Science BioTech

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

Health Populi

JUNE 18, 2020

Nine in ten Americans is concerned about the price of prescription drugs in the wake of the coronavirus pandemic, Gallup and West Health found in their survey on the cost of healthcare, published today. A majority of people across political party share this concern: overall, 88% of U.S. 84% of Republicans.

BioTech

BioTech Medicare Life Science Telehealth

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Health Populi

FEBRUARY 22, 2021

The reputation of the pharmaceutical industry gained a “whopping” 30 points between January 2020 and February 2021, based on the latest Harris Poll in their research into industries’ reputations. Right now they’re very science- and research-forward versus very business-forward.”. Why was this the case?

Life Science

Life Science Pharmaceuticals Public Health BioTech

Americans’ Concerns About the US Healthcare System Loom Larger Than Worries About Their Own Care

Health Populi

JUNE 9, 2020

are more concerned about other people not having access to high quality health care versus themselves. The coronavirus pandemic has further opened the kimono of the U.S. healthcare system to Americans: four months into the COVID-19 outbreak, most consumers (62%) of people in the U.S.

Life Science

Life Science Pharmaceuticals Public Health Health Policy

What Do Democrats and Republicans Agree On? Allowing Government & Business to Negotiate Lower Rx Prices

Health Populi

JUNE 3, 2021

have weathered over fifteen months of life-shifts for work, school, prayer, fitness, and social lives. So you might think that the most important public priority for Congress might have something to do with COVID-19, vaccines, or health insurance coverage. People living in the U.S.

Medicare

Medicare Life Science BioTech Pharmaceuticals

The State of the Union for Prescription Drug Prices

Health Populi

FEBRUARY 4, 2020

voters in 2020 quite like supporting Medicare’s ability to negotiate drug prices with pharmaceutical companies, shown by the October 2019 Kaiser Family Foundation Health Tracking Poll. This morning we don’t have a transcript of the speech ahead of the event, but one topic remains high on U.S. Few issues unite U.S.

Pharmaceuticals

Pharmaceuticals Medicare Leadership Life Science

Consumers Consider Cost When They Think About Medical Innovation

Health Populi

JULY 10, 2018

While the vast majority of Americans say that science has made life easier for most people, and especially for health care, people are split in questioning the financial cost and value of medical treatments, the Pew Research Center has found.

BioTech

BioTech Medical Billing Life Science Pharmaceuticals

How Tariffs Could Wreak Havoc on Health Care Costs and Supply Chains in the U.S.

Health Populi

JANUARY 15, 2025

Tariffs usually have unwanted or unintended side effects — typically, raising prices on goods and services that use the tariffed products in the production or delivery of their finished goods (such as pharmaceutical products or medical devices) — or services, as would be the case for health care providers and systems.

Pharmaceuticals

Pharmaceuticals Life Science Public Health Health Policy

Two-Thirds of Americans Say Healthcare Doesn’t Work Well, in RealClear Politics Poll

Health Populi

MAY 19, 2019

.” Health Populi’s Hot Points: RealClear asked people to consult their forecasting tea leaves to consider which industries and organizations would improve the quality of health care for Americans 20 years into the future.

Life Science

Life Science BioTech Medicare Medical Billing

Connected Health Pulse

What Person-Centered Interoperability Looks Like: Seqster

Health Care Nation – How to Inspire a Rosa Parks Moment for Healthcare in America?

Webinars

Trending Sources

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Webinars

McKinsey’s Six Shifts To Add Life to Years — and One More to Consider

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Well-Being Burnout – Lululemon’s 4th Annual Study Into Our Pressured Lives

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Social Determinants of Health – My Early Childhood Education and Recent Learnings, Shared at the HealthXL Global Gathering

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Medical costs projected to increase 6% by 2020, says PwC

Wasted: $1 of Every $4 Spent on Health Care In America

Can a Food-As-Medicine App Extend Chronic Health Management at the Grocery Store?

Healthcare AI investment will shift to these 5 areas in the next 2 years: survey

In 2020, PwC Expects Consumers to Grow DIY Healthcare Muscles As Medical Prices Increase

The 2021 Shkreli Awards: Lown Institute Counts Down the Top 10 Healthcare Industry Abuses in the Coronavirus Pandemic

Measuring Progress for Life Sciences: Trust, Patient Access, and Prevention at a Fork in the Road of Public Health

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Americans’ Concerns About the US Healthcare System Loom Larger Than Worries About Their Own Care

What Do Democrats and Republicans Agree On? Allowing Government & Business to Negotiate Lower Rx Prices

The State of the Union for Prescription Drug Prices

Consumers Consider Cost When They Think About Medical Innovation

How Tariffs Could Wreak Havoc on Health Care Costs and Supply Chains in the U.S.

Two-Thirds of Americans Say Healthcare Doesn’t Work Well, in RealClear Politics Poll

Stay Connected